LETTER TO THE EDITOR
Elderly woman presenting with unusual propriospinal myoclonus triggered by drug-induced nausea and vomiting
Byoung June Ahn,
Byoung June Ahn
Department of Neurology, Soonchunhyang University School of Medicine, Soonchunhyang University Gumi Hospital, Gumi, Korea
Search for more papers by this author Kyum-Yil Kwon,
Kyum-Yil Kwon
Department of Neurology, Soonchunhyang University School of Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea
Search for more papers by this author
Byoung June Ahn,
Byoung June Ahn
Department of Neurology, Soonchunhyang University School of Medicine, Soonchunhyang University Gumi Hospital, Gumi, Korea
Search for more papers by this author Kyum-Yil Kwon,
Kyum-Yil Kwon
Department of Neurology, Soonchunhyang University School of Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea
Search for more papers by this author
First published: 15 March 2018
No abstract is available for this article.
| Filename |
Description |
| ggi13237-sup-0001-VideoS1.avivideo/avi, 3.9 MB |
Video S1 The patient presented with propriospinal myoclonus a couple of weeks after administration of memantine (20 mg/day) and bupropion (150 mg/day), and showed considerable aggravation in the lateral position or with stimulus to the leg. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1van der Salm SM, Erro R, Cordivari C et al. Propriospinal myoclonus: clinical reappraisal and review of literature. Neurology 2014; 83: 1862–1870.
- 2Esposito M, Erro R, Edwards MJ et al. The pathophysiology of symptomatic propriospinal myoclonus. Mov Disord 2014; 29: 1097–1099.
- 3Termsarasab P, Thammongkolchai T, Frucht SJ. Spinal-generated movement disorders: a clinical review. J Clin Mov Disord 2015; 2: 18.
- 4Kojovic M, Cordivari C, Bhatia K. Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord 2011; 4: 47–62.
- 5Kitagawa N, Takeuchi A. Memantine-induced myoclonus. Neurology 2014; 83: 1387.
- 6Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 2006; 12: 178–207.
